Sharepoint Solutions
PRODUCTS
-
ACS ATOMUS® PF8 features an NSF/ANSI 61 certified and proprietary filtration solution for the water treatment industry specifically designed to remove PFAS forever chemicals from drinking water.
-
AES Box™ is a modular architectural system that delivers our best-in-class modular cleanroom design and integrates seamlessly with your current project infrastructure while providing the compliance and quality you need.
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
The AMERICAN Earthquake Joint System (Patent 10,436,367) combines the rugged, tough, and time-proven deflection performance of AMERICAN’s Flex-Ring restrained joint pipe with the capacity to expand and contract.
WHITE PAPERS AND CASE STUDIES
-
Biostatistics And Programming — More Than Just Clinical Trials
See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
Avoid Clinical Manufacturing Pitfalls With These Tech Transfer Best Practices
Ensure a smooth transition from development to manufacturing by implementing a strategic tech transfer process. Review key practices for effective communication, collaboration, and risk mitigation.
-
Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations
This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
FDA's Regenerative Medicine Advanced Therapy (RMAT) Program
RMAT qualification requires preliminary clinical evidence demonstrating the potential to address an unmet medical need. This designation grants benefits like intensive guidance and faster FDA review.
-
NDA Success Strategy: Using Non-US Clinical Data In An NDA Submission
A sponsor acquiring a therapeutic asset from an overseas company sought assistance when including foreign clinical trial dat,a generated outside a U.S. IND, in a New Drug Application (NDA).
-
Optimizing AAV Purification for High Recovery
How can you improve purification methods for your AAVs and enhance the efficacy and safety of your gene therapy treatments?
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
AOC GMP Manufacture For A FIH Study
Successful development of AOCs for FIH studies requires robust GMP processes and efficient scale-up. A key step is careful management of a multi-day conjugation process with vital in-process checks.
NEWS
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
FAU Tells 'Story' Of Atlantic's Sargassum Surge Using 40 Years Of Data8/28/2025
Researchers at Florida Atlantic University’s Harbor Branch Oceanographic Institute have released a landmark review tracing four decades of changes in pelagic sargassum – free-floating brown seaweed that plays a vital role in the Atlantic Ocean ecosystem.
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).
-
Pittsburgh Water Receives $26M In Grants And Low-Interest Loans From PENNVEST1/23/2025
Today, Pittsburgh Water announced the receipt of $26M in grants and low-interest loans from the Pennsylvania Infrastructure Investment Authority (PENNVEST) to continue the diligent removal of lead service lines throughout Pittsburgh’s drinking water system.
-
Dairy Producers Leverage Genetics To Optimize Milk Composition For Processing3/27/2025
Genetic improvements within the U.S. dairy herd are fueling historic gains in key milk components needed to produce cheese, butter and a variety of other popular dairy foods.